Vaccines for Children (VFC) FY26
Closed Solicitation Posted
- Solicitation number
- 000HCJBC-2025-95504
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Atlanta, Georgia 30341, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC) is soliciting proposals from manufacturers of pediatric vaccines for the Vaccines for Children (VFC) program, which provides federally supported immunizations to eligible children including Medicaid-eligible, uninsured, American Indian/Alaska Native, and children with limited vaccine coverage. This Indefinite Delivery/Indefinite Quantity (IDIQ) firm-fixed-price procurement covers 25 different vaccine types with maximum order quantities ranging from 50,000 to 13 million doses per vaccine. Offerors must be manufacturers of pediatric vaccines in compliance with 42 U.S.C. Section 1396s and must meet specific requirements including FDA product licensing, a minimum 12-month shelf life, and adherence to Current Good Manufacturing Practice Regulations. Evaluation will be based on technical compliance with FDA licensing and federal excise tax requirements, pricing competitiveness, and past performance. The deadline for proposal submission is January 14, 2026 at 1:00 PM EST, with questions due by December 24, 2025.
This solicitation includes no set-aside designations but establishes small business subcontracting goals of 12.17% for small businesses, 9.5% for small disadvantaged businesses, 1.61% for HUBZone small businesses, 2.3% for women-owned small businesses, and 2.62% for service-disabled veteran-owned small businesses. The combined maximum contract value for all resulting contracts is $13,361,773,853.93, with the performance period running from April 1, 2026 through March 31, 2027. Vaccines will be distributed through CDC's centralized vaccine tracking system to designated locations in Olive Branch, Mississippi and Clermont, Kentucky, with the CDC Office of Acquisition Services administering the contract from its Atlanta, Georgia location. The contract allows awardees to optionally purchase additional vaccine quantities beyond federally eligible children using state and local funds, thereby expanding the program's reach and impact on immunization coverage.
Notice text
The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of
pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the
most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children
(VFC) program established pursuant to Section 13631of the Omnibus Budget Reconciliation Act of
1993 (OBRA '93), guarantees federal support for the purchase and supply of sufficient quantities of
vaccine to the States to cover a defined group of children. The program helps assure the
implementation of effective immunization practices and proper use of vaccines to achieve higher
immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through
the VFC purchase program include those who are(1) Medicaid-eligible, (2) without health insurance,
(3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA '93), or (4) children
with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at
a Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health
care providers who agree to certain requirements are eligible through the States to receive free vaccine
through this VFC purchase program. The establishment of these contracts provides an opportunity to
utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those
available in the commercial marketplace. In addition, awardees may opt to purchase additional
quantities of vaccine under any resulting contract to provide immunizations for children who are not
federally vaccine-eligible children using state and local funds. Offerors for this requirement must be
manufacturers of pediatric vaccines in accordance with 42 U.S.C. (S)1396s. The term "manufacturer"
means any corporation, organization, or institution, whether public or private (including Federal, State,
and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or
distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture,
import, process, or distribute a vaccine.
Files
| File | Type | Posted |
|---|---|---|
| A19 Solicitation - 75D30126R73375 0001.pdf | ||
| A19 Solicitation 75D30126R73375 0001 Cover Page.pdf | ||
| A19 Solicitation - 75D30126R73375 0001 Pg 2-31.docx | DOCX document | |
| A19 Solicitation - 75D30126R73375 Pg 2-31 Version 5.docx | DOCX document | |
| A19 Solicitation - 75D30126R73375.pdf | ||
| A19 Attachment 3 - List of Products.docx | DOCX document | |
| A19 Attachment 1 - List of Pediatric Vaccines.docx | DOCX document | |
| A19 Attachment 2 - ADR Agreement.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response | Office of the Assistant Secretary for Preparedness and Response | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity